Pay in 4 interest-free payments of $32.73 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation
and antitumor effects and the ability to protect against myocardial damage
20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
PMID: 29518481
PubMed PMID: 15136795
AMD-070 Catalog No.:M10820-10 Enrofloxacin is a fluoroquinolone antibioticMavorixafor, also known as AMD11070, AMD070, X4P 001, is an orally bioavailable and potent CXCR4 inhibitor. AMD11070 is an antagonist of SDF 1 ligand binding (IC50 = 12. 5 1. 3 nM), inhibits SDF 1 mediated calcium flux (IC50 = 9. 0 2. 0 nM) and SDF 1 mediated activation of the CXCR4 receptor as measured by a Eu GTP binding assay (IC50 =39. 8 2. 5 nM) or a [(35)S] GTPS binding assay (IC50 =19. 0 4. 1 nM), and inhibits SDF 1 stimulated chemotaxis (IC50
US$ 1070.00
US$ 970.00
US$ 39.99
US$ 78.00
US$ 1895.00
US$ 130.00
US$ 507.62
US$ 1050.00
US$ 1995.00
US$ 38.00
US$ 199.00
US$ 100.00
US$ 1995.00
US$ 1895.00